tiprankstipranks
Trending News
More News >
Biotest AG (DE:BIO3)
:BIO3
Germany Market

Biotest (BIO3) Income Statement

Compare
2 Followers

Biotest Income Statement

Last quarter (Q4 2024), Biotest's total revenue was €203.50M, an increase of 10.42% from the same quarter last year. In Q4, Biotest's net income was €-3.50M. See Biotest’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 726.20M€ 684.60M€ 516.10M€ 515.60M€ 484.20M
Gross Profit
€ 223.80M€ 280.30M€ 124.90M€ 80.70M€ 130.10M
Operating Expenses
€ 129.30M€ 136.80M€ 133.40M€ 132.80M€ 132.60M
Depreciation and Amortization
€ 40.60M€ 35.90M€ 35.70M€ 31.10M€ 29.60M
EBITDA
€ 120.40M€ 179.00M€ 28.30M€ -17.70M€ 16.00M
Operating Income
€ 94.50M€ 143.50M€ -13.00M€ -52.10M€ -13.20M
Other Income/Expenses
€ -48.00M€ -37.20M€ -17.90M€ -15.60M€ -16.80M
Pretax Income
€ 46.50M€ 106.30M€ -30.80M€ -62.60M€ -30.00M
Net Income
€ 26.40M€ 127.00M€ -31.60M€ -63.30M€ -31.40M
Per Share Metrics
Basic EPS
€ 0.71€ 3.21€ -0.80€ -1.60€ -0.79
Diluted EPS
€ 0.71€ 3.21€ -0.80€ -1.60€ -0.79
Weighted Average Shares Outstanding
39.57M 39.57M 39.57M 39.57M 39.57M
Weighted Average Shares Outstanding (Diluted)
39.57M 39.57M 39.57M 39.57M 39.57M
Currency in EUR

Biotest Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis